Quest Diagnostics Investments, Inc.

Focus Diagnostics, Inc.

Qiagen Mansfield, Inc.

Ming-Chou Lee

Lilly I Kong

Michelle M Tabb

Jules Chen

Michael Aye

Fan Chen

Ning Lu

Jan Groen

Sergey V Voronov

Laurence R McCarthy

Vesselin Tenkov Diankov

Larry McCarthy

Disclosed herein are methods and compositions for detectingandby detecting the presence of the IS481 and IS1001 genomic insertion sequences, respectively.

Bordetella detection assay

detection assay

The present invention generally relates to a molecular test of Influenza A, Influenza B, Respiratory Syncytial Virus A, and Respiratory Syncytial Virus B in order to identify patients with a viral infection. Accordingly methods and compositions are disclosed to determine the presence or absence of a viral pathogen in a sample containing one or more target nucleic acids from the M gene of Influenza A, Influenza B, Respiratory Syncytial Virus A, and/or Respiratory Syncytial Virus B.

Multiplex detection assay for influenza and RSV viruses

Described are approaches for the identification, detection, and quantification of nucleic acids in a biological sample. These methods are based, in part, on the elucidation of anomalous migration properties of short nucleic acid molecules when conjugated to a fluorescent label, such as fluorescein labels, such that a smaller nucleic acid reliably migrates slower than a larger nucleic acid under the same conditions of separation.

Methods of nucleic acid quantification and detection using anomalous migration

The invention provides methods and compositions for rapid, sensitive, and highly specific nucleic acid-based (e.g., DNA based) detection of human rhinovirus (HRV) in a sample. In general, the methods involve detecting a target nucleic acid having a target sequence of a conserved 5' untranslated region of the HRV genome. The invention also features compositions, including primers, probes, and kits, for use in the methods of the invention.

Methods and compositions for detecting rhinoviruses

Disclosed are methods of identifying a methicillin-resistant(MRSA) or methicillin-sensitive(MSSA) in a sample. The present invention provides a diagnostic method comprising modification of sequences ofby converting non-methylated cytosine residues ultimately into thymidine residues in the target nucleic acid. The invention further provides for the detection of modified sequences derived from the spa gene, the mecA gene, and the integrated SCCmec cassette of

[object Object]

Growing community of inventors

Mission Viejo, CA, United States of America

Ming-Chou Lee